Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 4:08 AM
Ignite Modification Date:
2025-12-26 @ 3:05 AM
NCT ID:
NCT02158520
Group ID:
EG001
Title:
Arm B (Ipilimumab)
Description:
Patients receive ipilimumab 3 mg/kg IV over 90 minutes on day 1. Treatment repeats every 21 days for up to 4 courses in the absence of disease progression or unacceptable toxicity. Patients experiencing progressive disease may cross-over to Arm A within 2-4 weeks.
Deaths Number Affected:
8
Deaths Number At Risk:
None
Serious Number Affected:
4
Serious Number At Risk:
12
Other Number Affected:
9
Other Number At Risk:
12
Study:
NCT02158520
Results Section:
NCT02158520
Adverse Events Module:
NCT02158520